. Author manuscript; available in PMC: 2016 Apr 12.

Published in final edited form as: J Gastroenterol Hepatol. 2015 Oct;30(10):1543–1551. doi: 10.1111/jgh.12936

Table 1.

Demographic and clinical data characteristics of the enrolled subjects

Demographic characters	TN group (n = 20)	NR group (n = 20)	SVR group (n = 20)	Control group (n = 10)
Sex
Male : female	19:1	17:3	17:3	4:6
Age
Range (mean ± SD)	19–54 (42 ± 10.4)	21–54 (43.5 ± 8.6)	20–51 (40.3 ± 7.8)	42–64 (56 ± 6.8)
HCV viral load (10⁶ IU/mL, [mean ± SD])	1.3 ± 1.2	0.9 ± 0.8	NA	NA
Distribution of liver inflammatory grade
Grade 1–2	12	11	14
Grade 3–4	8	9	6	NA
Distribution of liver fibrosis stage
Stage 1–2	14	13	18
Stage 3–4	6	7	2	NA
ALT (IU/mL [mean ± SD])	50.9 ± 25.8	37 ± 22.5	32.5 ± 26.7	21 ± 7.4
AST (IU/mL [mean ± SD])	36.5 ± 21.9	32.2 ± 23	25.9 ± 18.9	23 ± 11

ALT, alanine aminotransferase; AST, aspartate aminotransferase; NA, not applicable; NR, non-responders; SVR, sustained virologic response; TN, treatment naïve.